Element Solutions ESI Q1 2026 Earnings EPS 041 Beats Estimates Securitize Reports 39 Revenue Growth Amid Planned Cantor Fitzgerald SPAC Merger Kaiser KALU Reports Strong Q1 2026 Revenue NA EPS Beats Wheeler WHLR Q2 2024 In Line Whats Next for Investors Bank of America Forecasts 10x Productivity Boost from AI as Implementation Gap Narrows Barclays Raises Energy Transfer ET Price Target Citing Undervaluation Tech IPOs Take a Backseat as Biotech and Healthcare Dominate US Public Listings Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday NFL Seeks to Ban Specific Sports Prediction Contracts Cites Integrity Concerns Fed Rate Hike Expectations Resurface as Inflation Data Stirs Market Runway Growth Finance Corp RWAY Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady MWA Q1 2026 Earnings EPS Beats Estimates by 647 Union Bankshares Inc UNB Q2 2025 Earnings Shares Gain on Reported EPS of 053 Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Sees Modest Stock Gain Reeds Inc REED Q1 2026 Earnings WiderthanExpected Loss Sends Stock Higher AGIO Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares Brookfield Renewable Partners BEP Holds Steady Near Resistance Amid Modest Decline IB Acquisition Corp IBAC Holds Steady at 1079 as Trading Remains Flat Encore Capital Group ECPG Declines 168 as Shares Approach Key Support Zone Community Healthcare Trust CHCT Rallies 104 as Support at 1668 Holds Firm Sutro Biopharma STRO Surges 6 Key Levels and Market Dynamics Tax Season 2025 New Rules for Online Sellers and EV Buyers Could Mean Savings EVC Q1 2026 Earnings Profitable Quarter Drives Positive Market Reaction Hall Chadwick Acquisition Corp Rights HCACR Hold Steady at 032 Waiting for a Catalyst OCUL Q1 2026 Earnings EPS Misses Estimates as PreCommercial Biotech Continues Development Independent Bank Corp INDB Q1 2026 Earnings Marginal EPS Miss Within Expectations STTK Q1 2026 Earnings Narrower Loss Surprises No Revenue as Pipeline Progress Continues ALDX Q1 2026 Earnings Narrower Loss Beats Estimates Pipeline Progress Highlights DSGN Q1 2026 Earnings EPS Beats Estimates as Development Stage Biotech Advances Pipeline TT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher VNDA Q1 2026 Earnings EPS Misses Estimates as Operating Costs Weigh on Results